Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Evelyn Arel Zalazar"'
Autor:
Carolina Di Benedetto, Carla Borini Etichetti, Nabila Cocordano, Alejo Cantoia, Evelyn Arel Zalazar, Silvio Bicciato, Mauricio Menacho-Márquez, Germán Leandro Rosano, Javier Girardini
Publikováno v:
Frontiers in Molecular Biosciences, Vol 10 (2023)
Alteration of metabolism in cancer cells is a central aspect of the mechanisms that sustain aggressive traits. Aldo–keto reductase 1 B1 (AKR1B1) catalyzes the reduction of several aldehydes to alcohols consuming NADPH. Nevertheless, the ability of
Externí odkaz:
https://doaj.org/article/e9df432b03644271ac974a401b73fcc9
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Missense mutations in the TP53 gene are among the most frequent alterations in human cancer. Consequently, many tumors show high expression of p53 point mutants, which may acquire novel activities that contribute to develop aggressive tumors. An unex
Externí odkaz:
https://doaj.org/article/d490cdccb0794cbe9ac6dd20c5de2fc1
Autor:
Evelyn Arel Zalazar, Nabila Cocordano, Sabrina Valente, Javier Girardini, Carla Borini Etichetti
Publikováno v:
Revista de la Facultad de Ciencias Médicas. Universidad Nacional de Rosario.. 2:15-28
ICMT cataliza el último paso de un proceso de modificación postraduccional que afecta residuos de cisteína C-terminal en ciertas proteínas. En los últimos años, varios estudios demostraron que puede desempeñar un papel en la carcinogénesis. B
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9ebad4ff1ef39cbb65a4e1d1ff9418ae
https://doi.org/10.35305/fcm.v2i.52
https://doi.org/10.35305/fcm.v2i.52
Autor:
María Sol Ballari, Exequiel O. J. Porta, Evelyn Arel Zalazar, Carla M. Borini Etichetti, José M. Padrón, Javier Girardini, Guillermo R. Labadie
Salirasib, or farnesylthiosalicylic acid (FTS), is a salicylic acid derivative with demonstrated antineoplastic activity. While designed as a competitor of the substrate S-farnesyl cysteine on Ras, it is a potent competitive inhibitor of isoprenylcys
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::49f0cbd3394d5a94130e6efdc3913f45
https://doi.org/10.26434/chemrxiv-2021-gkff1-v2
https://doi.org/10.26434/chemrxiv-2021-gkff1-v2
Publikováno v:
Frontiers in Oncology
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Frontiers in Oncology, Vol 10 (2020)
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Frontiers in Oncology, Vol 10 (2020)
Missense mutations in the TP53 gene are among the most frequent alterations in human cancer. Consequently, many tumors show high expression of p53 point mutants, which may acquire novel activities that contribute to develop aggressive tumors. An unex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::209cbbd2a76cd2a40bc6b8055c0e767d
https://doi.org/10.3389/fonc.2020.595034
https://doi.org/10.3389/fonc.2020.595034